Gardner Syndrome Treatment Market Report 2024: Analysis and Forecast Through 2018-2033 Featuring Biochem Pharmaceuticals Industries, Zydus Lifesciences, Vernalis (R&D), Sun Pharmaceutical ...
Sanofi - American Depositary Shares (SNY)
US:NYSE Investor Relations:
sanofi.com/en/investors
Company Research
Source: Yahoo! Finance
The global Gardner syndrome treatment market has grown steadily in recent years. It will grow from $18.38 billion in 2023 to $19.24 billion in 2024 at a compound annual growth rate (CAGR) of 4.6%. The growth observed during the historical period can be ascribed to progress in medical research, government regulations, the rising prevalence of Gardner syndrome, market competition, and improvements in healthcare infrastructure. The market is expected to see steady growth in the next few years. It will grow to $23.36 billion in 2028 at a compound annual growth rate (CAGR) of 5.0%. The anticipated growth in the forecast period can be linked to advancements in treatment innovations, market trends, global economic factors, patient preferences, as well as pricing and reimbursement policies. Key trends expected in the forecast period encompass advancements in precision medicine, breakthroughs in immunotherapy, innovation in gene therapy, developments in diagnostic technologies, and collabor
Show less
Read more
Impact Snapshot
Event Time:
SNY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SNY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SNY alerts
High impacting Sanofi - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
SNY
News
- Global Graft Versus Host Disease (GVHD) Clinical Trials Review 2024 [Yahoo! Finance]Yahoo! Finance
- GSK knew about Zantac cancer risk, attorneys tell jury in first trial [Reuters]Reuters
- GSK knew about Zantac cancer risk, attorneys tell jury in first trial [Yahoo! Finance]Yahoo! Finance
- Regeneron (REGN) Q1 Earnings, Sales Miss on Lower Eylea Sales [Yahoo! Finance]Yahoo! Finance
- E2open Announces Connect Europe 2024 Client Award Winners [Yahoo! Finance]Yahoo! Finance
SNY
Analyst Actions
- 2/12/24 - TheStreet
SNY
Sec Filings
- 5/2/24 - Form 6-K
- 4/25/24 - Form 6-K
- 4/4/24 - Form F-3ASR
- SNY's page on the SEC website